0000899243-21-001369.txt : 20210111
0000899243-21-001369.hdr.sgml : 20210111
20210111173723
ACCESSION NUMBER: 0000899243-21-001369
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210107
FILED AS OF DATE: 20210111
DATE AS OF CHANGE: 20210111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Baeuerle Patrick
CENTRAL INDEX KEY: 0001362054
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39856
FILM NUMBER: 21521802
MAIL ADDRESS:
STREET 1: WOLDPROMENADE 18C
CITY: GAUTING
STATE: 2M
ZIP: 82131
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cullinan Management, Inc.
CENTRAL INDEX KEY: 0001789972
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 813867811
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE MAIN STREET
STREET 2: SUITE 520
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-410-4650
MAIL ADDRESS:
STREET 1: ONE MAIN STREET
STREET 2: SUITE 520
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Cullinan Oncology, LLC
DATE OF NAME CHANGE: 20191001
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-01-07
0
0001789972
Cullinan Management, Inc.
CGEM
0001362054
Baeuerle Patrick
C/O CULLINAN MANAGEMENT, INC.
ONE MAIN STREET, SUITE 520
CAMBRIDGE
MA
02142
0
1
0
0
See Remarks
Stock Option (Right to Buy)
21.00
2021-01-07
4
A
0
286665
0.00
A
2031-01-06
Common Stock
286665
286665
D
The option represents a right to purchase a total of 286,665 shares of the Issuer's Common Stock, 25% of which will become fully vested and exercisable on January 7, 2022, with the remaining shares vesting in equal monthly installments over the following three years (36 months), subject to the reporting person's continued employment with the Issuer.
Acting Chief Scientific Officer, Biologics
/s/ Jeffrey Trigilio, attorney-in-fact
2021-01-07